Severe retinopathy in type 1 diabetic patients is not related to the level of plasma homocysteine

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 60, Issue 3, 2000, Pages 169-174

  Agardh, E ^a   Hultberg, B ^a   Agardh, Carl David ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diabetes mellitus; Homocysteine; Nephropathy; Retinopathy

Indexed keywords

HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD VESSEL INJURY; CLINICAL ARTICLE; CORRELATION FUNCTION; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL;

GLOMERULUS;

EID: 0034130228     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655100750044811     Document Type: Article

References (20)

1. 1 Mudd SH, Harvey LL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited disease, 6th ed. New York: McGraw-Hill, 1989: 693-734.
2. 2 Refsum H, Ueland PM, Nygård O, Wollset SE. Homocysteine and cardiovascular disease. Ann Rev Med 1998; 49: 31-62.
3. 3 Hultberg B, Agardh E, Andersson A, Brattsröm L, Isaksson A, Israelsson B, Agardh C-D. Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type I diabetes mellitus. Scand J Clin Lab Invest 1991; 51: 277-82.
4. 4 Agardh C-D, Agardh E, Andersson A, Hultberg B. Lack of association between plasma homocysteine levels and microangiopathy in type I diabetes mellitus. Scand J Clin Lab Invest 1994; 54: 637-41.
5. 5 Hultberg B, Agardh C-D, Agardh E, Lövestam-Adrian M. Poor metabolic control, early age at onset, and marginal folate deficiency are associated with increasing levels of plasma homocysteine in insulin-dependent diabetes mellitus. A five-year follow-up study. Scand J Clin Lab Invest 1997; 57: 595-600.
6. 6 Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmol 1991; 98: 766-85.
7. 7 Andersson A, Isaksson A, Brattström L, Hultberg B. Homocysteine and other thiols determined in plasma by HPLC and thiol-specific postcolumn derivatization. Clin Chem 1993; 39: 1590-97.
8. 8 Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-86.
9. 9 Feener PE, King GL. Vascular dysfunction in diabetes mellitus. Lancet 1997; 350 Suppl I: 9-13.
10. 10 Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 1996; 98: 5-7.
11. 11 Stamler JS, Osborne JA, Jaraki O, Mullins M, Single D, Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993; 91: 308-11.
12. 12 Tsai JC, Wang H, Perella MA, Yoshizumi M, Sibinga NES, Tan LC, Haber E, Chang THTC, Schlegel R, Lee ME. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest 1996; 97: 146-53.
13. 13 Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Schmidt AM, Fiehn W, Ziegler R, Wahl P, Nawroth PP. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care 1998; 21: 841-8.
14. 14 Bostom A, Brosnan JT, Hall B, Nadeau MR, Selhub J. Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis 1995; 116: 59-62.
15. 15 Chico A, Pérez A, Córdoba A, Arcelús R, Carreras G, de Leiva A, González-Sastre F, Blanco-Vaca F. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia 1998; 41: 684-93.
16. 16 Agardh C-D, Eckert B, Agardh E. Irreversible progression of severe retinopathy in young type I insulin-dependent diabetes mellitus patients after improved metabolic control. J Diabet Comp 1992; 6: 96-100.
17. 17 Moslkalets E, Galstyan G, Starostina E, Antisiferov M, Chantelau E. Association of blindness to intensification of glycemic control in insulin-dependent diabetes mellitus. J Diabet Comp 1994; 8: 45-50.
18. 18 Lövestam-Adrian M, Agardh E, Agardh C-D. The temporal development of retinopathy and nephropathy in type I diabetes mellitus during 15 years diabetes duration. Diabet Res Clin Pract 1999; 45: 15-23.
19. 19 Agardh E, Tallroth G, Bauer B, Cavallin-Sjöberg U, Agardh C-D. Retinopathy and nephropathy in insulin-dependent diabetics: an inconsistent relationship? Diabet Med 1987; 4: 248-50.
20. 20 Lövestam-Adrian M, Agardh E, Agardh C-D. The incidence of nephropathy in type I diabetic patients with proliferative retinopathy: a 10-year follow-up study. Diabet Res Clin Pract 1998; 39: 11-7.